NCT06500351 Renalase(rs10887800) Genotyping & Leucocytes Telomere Length in Postpartum. Hypertension
| NCT ID | NCT06500351 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sohag University |
| Condition | Renalase(rs10887800) Genotyping & Leucocytes Telomere Length in Patients With Postpartum Hypertension |
| Study Type | OBSERVATIONAL |
| Enrollment | 90 participants |
| Start Date | 2024-06-25 |
| Primary Completion | 2025-06-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 90 participants in total. It began in 2024-06-25 with a primary completion date of 2025-06-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is an observertional study aimed at Study the association between Renalase(rs10887800) Genotyping \& Leucocytes telomere length in patients with postpartum hypertension whether new onset( denovo) or persistent following pregnancy complicated by hypertension.
Eligibility Criteria
Inclusion Criteria: * Patients who are18 years or above, and have a diagnosis of postpartum hypertension(regardless of where they received their antenatal care) attended to Sohag university hospitals Exclusion Criteria: * All pregnant women with medical disorders in pregnancy other than Hypertensive disorders during pregnancy (e.g., sickle cell disease, heart disease, kidney and other connective tissues disorders) will be excluded from the study. Also we excluded measurements taken during scheduled or unscheduled surgical encounters given potential for interaction with anesthetic agents
Contact & Investigator
Amera Morad Foad, assistant professor
PRINCIPAL INVESTIGATOR
Sohag University
Frequently Asked Questions
Who can join the NCT06500351 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 45 Years, studying Renalase(rs10887800) Genotyping & Leucocytes Telomere Length in Patients With Postpartum Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06500351 currently recruiting?
Yes, NCT06500351 is actively recruiting participants. Contact the research team at ameramoradfoad@gmail.com for enrollment information.
Where is the NCT06500351 trial being conducted?
This trial is being conducted at Sohag, Egypt.
Who is sponsoring the NCT06500351 clinical trial?
NCT06500351 is sponsored by Sohag University. The principal investigator is Amera Morad Foad, assistant professor at Sohag University. The trial plans to enroll 90 participants.